IDH2 and acute myeloid leukemia: In an initial study, Andersson et al. explored IDH mutations in a population of 515 pediatric acute leukemia patients: IDH1 and IDH2 mutations were very rare in ALLs (1/288) and more frequent in AML (3.5%), with a higher frequency in AMLs with normal karyotype (9.8%).